The discrepancy surrounding the protective effect of TRPA1 in atherosclerosis might be caused by the use of different macrophage sources (BMDMs vs. THP-1 derived macrophages) and the different stimuli (Ox-LDL vs. LPC) [99]. The gene discussed is TRPA1; the disease is atherosclerosis.